SSSana Sarkar

Sana Sarkar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sana Sarkar has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Anuj Pandey

    Systems Toxicology Group, Food, Drug & Chemical, Environment and Systems Toxicology (FEST) Division, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, India

    3 shared publications
  • Aditya Bhushan Pant

    Systems Toxicology Group, Food, Drug & Chemical, Environment and Systems Toxicology (FEST) Division, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, India

    2 shared publications
  • Sanjay Yadav

    All India Institute of Medical Sciences (AIIMS) Raebareli India

    2 shared publications
  • Abhishek Jauhari

    Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR- Indian Institute of Toxicology Research, Lucknow, India

    1 shared publication
  • Bushra Khan

    Systems Toxicology Group, Food, Drug & Chemical, Environment and Systems Toxicology (FEST) Division, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, India

    1 shared publication
  • Devendra Parmar

    Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR- Indian Institute of Toxicology Research, Lucknow, India

    1 shared publication

Latest Publications

  • Open Access

    Comparative evaluation of the cytokine profile in platelet-rich fibrin and hyperacute serum from periodontitis patients with or without type 2 diabetes mellitus: An ex vivo cross-sectional study

    by Vivek Kumar Bains, Jaideep Mahendra, Madhukar Mittal, Gunam Valli, Pankhi Vatsa, Sana Sarkar, Little Mahendra, Prakhar Pant

    Periodontitis is regarded as the 6th microvascular complication of type 2 diabetes mellitus (T2DM). In individuals with both periodontitis and T2DM, the condition may adversely influence the regenerative potential of the platelet-rich fibrin (PRF) and hyperacute serum (HAS) derived from these patients. The present cross-sectional study was conducted to evaluate the weight and cytokine levels of the PRF and HAS obtained from periodontitis patients with or without T2DM in a laboratory setting. Platelet-rich fibrin and HAS were obtained from 17 periodontitis patients with T2DM (group 1: T2DM+/P+), 17 periodontitis patients without T2DM (group 2: T2DM-/P+), and 16 periodontally healthy participants (group 3: T2DM-/P-). Demographic, periodontal and hematological parameters were recorded for all participants. Serum, PRF and HAS samples were quantified and analyzed for inflammatory markers - interleukin-6 (IL-6), resistin (RETN), tumor necrosis factor-alpha (TNF-α), IL-1β, and interleukin-1 receptor antagonist (IL-1ra) - as well as growth factors, including insulin-like growth factor-1 (IGF-1), transforming growth factor-beta 1 (TGF-β1), platelet-derived growth factor-BB (PDGF-BB), and fibroblast growth factor-21 (FGF-21). The quantities of PRF and HAS obtained were significantly higher in healthy individuals as compared to diabetic patients. The concentrations of inflammatory markers and growth factors in serum, PRF and HAS from periodontitis patients were not significantly different between those with and without T2DM. Periodontitis in conjunction with T2DM may influence the weight of PRF and HAS; however, no significant association was observed with respect to the levels of inflammatory markers and growth factors.


  • Open Access

    Integrative assessment of RNA sequencing and in silico analysis to pinpoint mRNAs, lncRNAs, and circRNAs interactions with miRNAs underlying arsenic-induced neurotoxicity

    by Sana Sarkar, Anuj Pandey, Bushra Khan, A. B. Pant

    The acquisition of neurodegeneration hallmarks necessitates molecular changes at multiple levels of functional genomics. Regulatory RNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play crucial roles in modulating messenger RNAs (mRNAs) expression and are potential molecules that regulate multifactorial neurotoxicity mechanisms. Integrated studies of regulatory RNAs’ functions are still lacking to portray the complete picture. In this study, we carried out a detailed analysis of mRNA, lncRNA, and circRNA profiles in differentiated SH-SY5Y cells exposed to arsenic, a well-known neurotoxicant, using the Illumina Novaseq6000 platform. Subsequently, employing a bioinformatics approach, we identified specific interactions between these RNA molecules and potential miRNAs, unraveling intricate regulatory networks. Among significantly deregulated transcripts, we identified 2487 mRNA transcripts, 1192 lncRNA transcripts, and 20 circRNA transcripts in arsenic-treated cells compared to control. Functional enrichment analysis indicated their involvement in numerous pathways underlying neurotoxicity. Further, these regulatory molecules displayed strong interactions with multiple miRNAs implicated in neuronal damage. Our findings revealed intricate molecular alterations in response to arsenic exposure, emphasizing the crucial role of multi-omics technologies in understanding neurodegeneration. This approach has enabled the identification of potential targets for future exploration, emphasizing the precise modulation of regulatory RNA networks to mitigate the effects of arsenic. • Arsenic exposure deregulates coding and non-coding elements in neuronal cells. • Identified mRNAs, lncRNAs, and circRNAs enriched in neurotoxicity & neurodegeneration. • Targeting miRNAs implicated in pathologies linked to various neurodegenerative diseases.


  • MicroRNA‐29b‐3p degenerates terminally differentiated dopaminergic SH‐SY5Y cells by perturbation of mitochondrial functions

    by Sana Sarkar, Anuj Pandey, Sanjeev Kumar Yadav, Pragati Raghuwanshi, Mohammed Haris Siddiqui, Saripella Srikrishna, Aditya Bhushan Pant, Sanjay Yadav

    Mitochondrial dysfunction is the main cause of gradual deterioration of structure and function of neuronal cells, eventually resulting in neurodegeneration. Studies have revealed a complex interrelationship between neurotoxicant exposure, mitochondrial dysfunction, and neurodegenerative diseases. Alteration in the expression of microRNAs (miRNAs) has also been linked with disruption in mitochondrial homeostasis and bioenergetics. In our recent research (Cellular and Molecular Neurobiology (2023) https://doi.org/10.1007/s10571‐023‐01362‐4), we have identified miR‐29b‐3p as one of the most significantly up‐regulated miRNAs in the blood of Parkinson's patients. The findings of the present study revealed that neurotoxicants of two different natures, that is, arsenic or rotenone, dramatically increased miR‐29b‐3p expression (18.63‐fold and 12.85‐fold, respectively) in differentiated dopaminergic SH‐SY5Y cells. This dysregulation of miR‐29b‐3p intricately modulated mitochondrial morphology, induced oxidative stress, and perturbed mitochondrial membrane potential, collectively contributing to the degeneration of dopaminergic cells. Additionally, using assays for mitochondrial bioenergetics in live and differentiated SH‐SY5Y cells, a reduction in oxygen consumption rate (OCR), maximal respiration, basal respiration, and non‐mitochondrial respiration was observed in cells transfected with mimics of miR‐29b‐3p. Inhibition of miR‐29b‐3p by transfecting inhibitor of miR‐29b‐3p prior to exposure to neurotoxicants significantly restored OCR and other respiration parameters. Furthermore, we observed that induction of miR‐29b‐3p activates neuronal apoptosis via sirtuin‐1(SIRT‐1)/YinYang‐1(YY‐1)/peroxisome proliferator‐activated receptor‐gamma coactivator‐1alpha (PGC‐1α)‐regulated Bcl‐2 interacting protein 3‐like‐dependent mechanism. Collectively, our studies have shown the role of miR‐29b‐3p in dysregulation of mitochondrial bioenergetics during degeneration of dopaminergic neurons via regulating SIRT‐1/YY‐1/PGC‐1α axis. image


  • Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson’s Disease

    by Sanjeev Kumar Yadav, Abhishek Jauhari, Nishant Singh, Anuj Pandey, Sana Sarkar, Shweta Pandey, Ravindra K. Garg, Devendra Parmar, Sanjay Yadav

    Parkinson's disease (PD) is a neurodegenerative disorder caused by the selective destruction of dopaminergic neurons (DA-nergic). Clinically, PD is diagnosed based on developing signs and symptoms. A neurological and physical examination and sometimes medical and family history also help in the diagnosis of PD. However, most of these features are visible when more than 80% of the dopaminergic neurons have degenerated. An understanding of the selective degeneration process at the cellular and molecular level and the development of new biomarkers are required for effective PD management. Several studies have been carried out using a selected set of miRNAs/ mRNAs and proteins to develop biomarkers of PD; however, an unbiased and combined miRNA–protein profiling study was required to identify the markers of progressive and selected degeneration of dopaminergic neurons in PD patients. In the present study, we have carried out global protein profiling through LC–MS/MS and miRNA profiling by using a “brain-specific” miRNA array panel of 112 miRNAs in PD patients and healthy controls to find the unprejudiced group of proteins and miRNAs that are deregulating in PD. In the whole blood samples of PD patients compared to healthy controls, the expression of 23 miRNAs and 289 proteins was significantly increased, whereas the expression of 4 miRNAs and 132 proteins was considerably downregulated. Network analysis, functional enrichment, annotation, and analysis of miRNA–protein interactions were also performed as part of the bioinformatics investigation of the discovered miRNAs and proteins revealing several pathways that lead to PD development and pathogenesis. Based on the analysis of miRNA and protein profiling, we have identified four miRNAs (hsa-miR-186-5p, miR-29b, miR-139 & has-miR-150-5p) and four proteins (YWHAZ, PSMA4, HYOU1, & SERPINA1), which can be targeted for the development of new biomarkers of PD. In vitro studies have identified the role of miR-186-5p in regulating the levels of the YWHAZ/YWHAB & CALM2 gene, which has shown maximum downregulation in PD patients and is known for its role in neuroprotection from apoptotic cell death & calcium regulation. In conclusion, our research has identified a group of miRNA–proteins that can be developed as PD biomarkers; however, future studies on the release of these miRNAs and proteins in extracellular vesicles circulating in the blood of PD patients can further validate these as specific biomarkers of PD. Graphical Abstract